Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy and safety of TLN-4601 used to treat
patients with Glioblastoma Multiforme(GBM) that recur/progress after receiving first line
systemic therapy post surgery/radiotherapy.